Experiences With and Challenges Afforded by Expedited Regulatory Pathways
Clin Pharmacol Ther
.
2019 Apr;105(4):795-797.
doi: 10.1002/cpt.1365.
Authors
Sheng Liu
1
,
Aaron S Kesselheim
1
Affiliation
1
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
30883712
DOI:
10.1002/cpt.1365
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Costs and Cost Analysis / economics*
Drug Approval / economics*
Drug Industry / economics*
Humans
Prescription Drugs / economics*
Time Factors
Substances
Prescription Drugs